NCT06897631 Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients
| NCT ID | NCT06897631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jing Tao |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-29 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-04-29 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effectiveness of Robot-Assisted Tai Chi Training (RATT) versus conventional rehabilitation in improving upper limb motor function post-stroke, and to explore the neuromuscular mechanisms of RATT. Participants will be randomly assigned to one of two groups: 1. Robot-Assisted Tai Chi Training group: Participants will receive guided Tai Chi arm movements with robotic assistance to enhance coordination and strength. 2. Conventional rehabilitation group: Participants will perform standard exercises (e.g., stretching, repetitive task practice). Both groups will receive 60-minute sessions, administered 5 days a week, over 4 weeks. Researchers will measure improvements using clinical scales (e.g., Fugl-Meyer Assessment) and monitor safety.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with stroke confirmed by neuroimaging (CT/MRI). 2. Fugl-Meyer Assessment for Upper Extremity score of 8-44. 3. First-ever stroke, with unilateral hemiplegia and time since onset ≤12 months. 4. Aged 40-80 years, regardless of gender. 5. Voluntarily participated and provided written informed consent. Participants meeting all above criteria were enrolled. Exclusion Criteria: 1. Severe cognitive impairment (Montreal Cognitive Assessment score \<10). 2. Poor sitting balance (\< Grade 2) or inability to maintain seated position for \>60 minutes. 3. Hypertonia (modified Ashworth Scale score \>2 in affected limb). 4. Significant hemiplegic shoulder pain (Visual Analogue Scale \>3). 5. Severe aphasia (Boston Diagnostic Aphasia Examination score \<3). 6. Severe visual impairment precluding robot-assisted upper limb training. 7. Moderate-to-severe depression (17-item Hamilton Depression Rating Scale score \>17). 8. Pre-existing neuromuscular disorders, active malignancies, or uncontrolled systemic diseases (cardiac, renal, hepatic). 9. Concurrent participation in other clinical trials affecting study outcomes. Participants meeting any of the above criteria were excluded.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06897631 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06897631 currently recruiting?
Yes, NCT06897631 is actively recruiting participants. Contact the research team at jingsongwu01@163.com for enrollment information.
Where is the NCT06897631 trial being conducted?
This trial is being conducted at Fuzhou, China, Fuzhou, China.
Who is sponsoring the NCT06897631 clinical trial?
NCT06897631 is sponsored by Jing Tao. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.